⌘K
Loading ticker…
As of 2026-08-24, Enanta Pharmaceuticals, Inc (ENTA) has a 3-month relative strength percentile of 51 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 54. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 4.7%, relative volume 1.90×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
ENTA is held by 18 ETFs as of May 2026. Top owner: VTWO at 0.01% weight, $2M notional. Top 3 carry $5M.
Held by 36 ETFs · $39M across latest filings · largest weight 0.37% (QQQS).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Related searches
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $143K |
| — |
| QQQS | 0.37% | $71K | −0.10 pp |
| VTHRVanguard Russell 3000 ETF | 0.00% | $30K | — |
| IBBQ | 0.03% | $20K | — |
| MSSM | 0.00% | $17K | — |
Showing 10 of 18 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ENTA Jan avg: 3.63% median: 1.81% win: 50% σ: 22.12% n: 4 2022-04-12 → 2026-07-31 | ENTA Feb avg: 18.06% median: 14.56% win: 75% σ: 25.57% n: 4 2022-04-12 → 2026-07-31 | ENTA Mar avg: -8.96% median: -14.15% win: 25% σ: 21.58% n: 4 2022-04-12 → 2026-07-31 | ENTA Apr avg: -5.10% median: -12.09% win: 40% σ: 14.40% n: 5 2022-04-12 → 2026-07-31 | ENTA May avg: -17.82% median: -9.24% win: 0% σ: 16.80% n: 5 2022-04-12 → 2026-07-31 | ENTA Jun avg: 10.36% median: 10.79% win: 80% σ: 13.85% n: 5 2022-04-12 → 2026-07-31 | ENTA Jul avg: 1.16% median: 0.27% win: 60% σ: 13.92% n: 5 2022-04-12 → 2026-07-31 | ENTA Aug avg: -3.31% median: -1.17% win: 50% σ: 16.48% n: 4 2022-04-12 → 2026-07-31 (current) | ENTA Sep avg: -4.16% median: -17.18% win: 25% σ: 31.37% n: 4 2022-04-12 → 2026-07-31 | ENTA Oct avg: -8.04% median: -10.73% win: 25% σ: 11.91% n: 4 2022-04-12 → 2026-07-31 | ENTA Nov avg: 1.48% median: 0.31% win: 50% σ: 21.58% n: 4 2022-04-12 → 2026-07-31 | ENTA Dec avg: -3.62% median: 3.49% win: 75% σ: 20.18% n: 4 2022-04-12 → 2026-07-31 |